Joshua M. Zachariah - Partner


Joshua M. Zachariah joshua.zachariah@kirkland.com Download V-Card New York Phone: +1 212-446-6450 Fax: +1 212-446-6460 Corporate Corporate Governance & Counseling Mergers & Acquisitions 2006, New York Georgetown University Law Center, J.D., 2005 Georgetown Journal of Legal Ethics, Articles Editor Duke University, B.S., Economics, 2002 summa cum laude Phi Beta Kappa	11/29/2012 Financial Times \| Awards & Rankings U.S. Innovative Lawyers Report 6/29/2012 The New York Times Dealbook \| Press Mentions Bristol-Myers in Deal for Amylin Valued at $7 Billion Kirkland represents Bristol-Myers Squibb Company in its agreement announced to acquire Amylin Pharmaceuticals for a total transaction value of approximately $7 billion. 1/9/2012 The Am Law Daily \| Press Mentions Kirkland, Dechert Advise as Bristol-Myers Squibb Acquires Inhibitex for $2.5 Billion Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc. 9/15/2011 Kirkland & Ellis LLP \| Press Releases Kirkland & Ellis LLP Appoints New Partners 9/8/2010 Reuters News \| Press Mentions Bristol to Acquire ZymoGenetics for $885 Million Kirkland represented Bristol-Myers Squibb Co. in its acquisition of ZymoGenetics Inc in a deal valued at $885 million.